Showing results (81-90 of 109) with videos related to
Sort By:
Pageof 11
British Journal of Haematology|August 1, 1990
Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myelomaD J Gottlieb, H G Prentice, A B Mehta, et al.Plos One|April 6, 2018
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutationL Lavalle, A S Thomas, B Beaton, et al.Pharmaceutical Research|January 20, 2011
Porous EH and EH-PEG scaffolds as gene delivery vehicles to skeletal muscleErin E Falco, Martha O Wang, Joshua A Thompson, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Long-term outcomes of liver transplantation in type 1 Gaucher diseaseR M Ayto, D A Hughes, P Jeevaratnam, et al.Oncogene|May 6, 1999
Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanismK Mengubas, F A Riordan, C A Bravery, et al.Indian Heart Journal|February 27, 2009
Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo RegistryAshok Seth, Nakul Sinha, Keyur Parikh, et al.Blood|September 1, 1989
In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantationH E Heslop, D J Gottlieb, A C Bianchi, et al.Indian Heart Journal|September 1, 1989
Coronary arteriographic findings soon after non Q wave myocardial infarctionJ A Parikh, P Sharma, A D Abhyankar, et al.British Journal of Cancer|July 1, 1991
Fludarabine phosphate for the treatment of low grade lymphoid malignancyJ S Whelan, C L Davis, S Rule, et al.Clinical Radiology|March 1, 1986
Non-Hodgkin's lymphoma: a survey from a district general hospitalA B Mehta, J P Evans, T O Kumaran, et al.Pageof 11